Evinacumab—a treatment for homozygous familial hypercholesterolemia

International Journal of Surgery: Global Health Pub Date : 2023-08-25 DOI:10.1097/GH9.0000000000000254

A. Basaria, Ismat Fatima, N. Raufi

引用次数: 0

Abstract

A rare life-threatening condition known as homozygous familial hypercholesterolemia (HoFH) is characterized by markedly elevated levels of low-density lipoprotein cholesterol (LDL-C) in the blood and accelerated, premature atherosclerotic cardiovascular disease (ACVD) [1] . It is clinically characterized by extensive xanthomas, marked premature and progressive ACVD

查看原文本刊更多论文

evinacumab -治疗纯合子家族性高胆固醇血症

纯合子家族性高胆固醇血症(HoFH)是一种罕见的危及生命的疾病，其特征是血液中低密度脂蛋白胆固醇(LDL-C)水平显著升高，加速过早动脉粥样硬化性心血管疾病(ACVD)[1]。临床表现为广泛的黄瘤，明显的早发性和进行性ACVD

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Surgery: Global Health

自引率

0.00%

发文量